pharma · Glioblastoma, IDH-wildtype · SHPH
Shuttle Pharmaceuticals Holdings
Shuttle Pharmaceuticals Holdings patent portfolio — 9 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Rockville, USA
- Founded
- 2012
- Employees
- 5
- Programs
- 1
- Drugs
- 1
- Patents
- 9
Shuttle Pharmaceuticals Holdings patents
9 pharmaceutical patents indexed for Shuttle Pharmaceuticals Holdings. 0 expire within 24 months.
Shuttle Pharmaceuticals Holdings has 9 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12357650
Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorlylase inhibitors in combination with radiation
granted -
US 12077515
Selective histone deacetylase inhibitors for the treatment of human disease
granted -
US 11654157
Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiation
granted -
US 11584733
Selective histone deacetylase inhibitors for the treatment of human disease
granted -
US 11407723
Selective histone deacetylase inhibitors for the treatment of human disease
granted -
US 11034667
Selective histone deacetylase inhibitors for the treatment of human disease
granted -
US 10745352
Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
granted -
US 10730834
Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
granted -
US 9809539
Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
granted
Frequently asked questions
How many patents does Shuttle Pharmaceuticals Holdings have?
9 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Shuttle Pharmaceuticals Holdings patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.